Perfil lipídico e uso de anti-TNF-α

Van Doornum, 2002, Accelerated atherosclerosis: an extra articular feature of rheumatoid arthritis?, Arthritis Rheum., 46, 862, 10.1002/art.10089 Lindhardsen, 2011, The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort study, Ann Rheum Dis., 70, 929, 10.1136/ard.2010.143396 van Halm, 2006, Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study, Arthritis Res Ther., 8, R151, 10.1186/ar2045 Del Porto, 2007, Response to anti-tumour necrosis factor alpha blockade is associated with reduction of carotid intima-media thickness in patients with active rheumatoid arthritis, Rheumatology., 46, 1111, 10.1093/rheumatology/kem089 Popa, 2007, The role of TNF-α in chronic inflammatory conditions, intermediary metabolism and cardiovascular risk, J Lipid Res., 48, 751, 10.1194/jlr.R600021-JLR200 Sherman, 1988, Recombinant human tumor necrosisfactor administered as a five-day continuous infusion in cancer patients: phase I toxicity and effects on lipid metabolism, J Clin Oncol., 6, 344, 10.1200/JCO.1988.6.2.344 van Eijk, 2009, Improvement of lipid profile is accompanied by atheroprotective alterations in highdensity lipoprotein composition upon tumor necrosis factor blockade. A prospective cohort study in ankylosing spondylitis, Arthritis & Rheum., 60, 1324, 10.1002/art.24492 Castro KR, Aikawa NE, Saad CG, Moraes JCB, Medeiros AC, Mota LMH, et al. Infliximab induces increase in triglyceride levels in psoriatic arthritis patients. Clin Dev Immunol. 2011.[In Press]. Daïen, 2012, Effect of TNF inhibitors on lipid profile in rheumatoid arthritis: a systematic review with meta-analysis, Ann Rheum Dis, 71, 862, 10.1136/annrheumdis-2011-201148 Popa, 2007, Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis, Ann Rheum Dis, 66, 1503, 10.1136/ard.2006.066191 Kiortsis, 2006, Effects of infliximab treatment on lipoprotein profile in patients with rheumatoid arthritis and ankylosing spondylitis, J Rheumatol, 33, 921 Tam, 2007, Impact of TNF inhibition on insulin resistance and lipids levels in patients with rheumatoid arthritis, Clin Rheumatol, 26, 1495, 10.1007/s10067-007-0539-8 Soubrier, 2008, Effects of anti-tumor necrosis factor therapy on lipid profile in patients with rheumatoid arthritis, Joint Bone Spine, 75, 22, 10.1016/j.jbspin.2007.04.014 Peters, 2007, Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis, Ann Rheum Dis, 66, 958, 10.1136/ard.2006.059691 Perez-Galan, 2006, Influence of tumor necrosis alpha blockade with infliximab on lipid profile in patients with active rheumatoid arthritis, Med Clin (Barc), 126, 757 Wijbrandts, 2009, Sustained changes in lipid profile and macrophage migration inhibitory factor (MIF) levels after anti- TNF therapy in rheumatoid arthritis, Ann Rheum Dis, 68, 1316, 10.1136/ard.2007.086728 Rosenson RS. Approach to the patient with hypertriglyceridemia. In: Freeman MW, Rind DM (eds.), Up to date. Disponível em: www.uptodate.com. [Acessado em junho de 2012]. Tirosh, 2007, Changes in triglyceride levels and risk of coronary heart disease in young men, Ann Intern Med, 147, 377, 10.7326/0003-4819-147-6-200709180-00007 Garcês, 2008, Anti-tumour necrosis factor agents and lipid profile: a class effect?, Ann Rheum Dis, 67, 895, 10.1136/ard.2007.078287 Jacobson, 2007, Treatment with anti TNF blockers and mortality risk in patients with rheumatoid arthritis, Ann Rheum Dis, 66, 670, 10.1136/ard.2006.062497